AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 152 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.86 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $243,000 | +5.2% | 6,936 | +43.7% | 0.01% | +25.0% |
| Q4 2019 | $231,000 | +8.5% | 4,828 | -26.6% | 0.00% | -33.3% |
| Q3 2019 | $213,000 | -65.2% | 6,582 | -27.5% | 0.01% | -75.0% |
| Q1 2019 | $612,000 | -9.1% | 9,075 | +10.3% | 0.02% | -52.0% |
| Q1 2018 | $673,000 | +28.4% | 8,228 | +4.8% | 0.05% | +19.0% |
| Q3 2017 | $524,000 | -11.9% | 7,851 | -22.9% | 0.04% | -23.6% |
| Q1 2017 | $595,000 | -9.2% | 10,189 | +72.8% | 0.06% | -52.2% |
| Q2 2015 | $655,000 | – | 5,895 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |